health canada semaglutide approves 1st generic version of Ozempic in the country Orbicular Announces Health Canada Approval

Consult Your Healthcare Provider: If constipation persists or becomes bothersome, don't hesitate to discuss it with your healthcare provider

Semaglutide for weight loss: An overview Semaglutide has gained attention for its capacity to support weight loss in people with and without diabetes

1 Weight loss results: Semaglutide 0.5 mg: -4.6 kg vs dulaglutide 0.75 mg: -2.3 kg Semaglutide 1.0 mg: -6.5 kg vs dulaglutide 1.5 mg: -3.0 kg Treatment difference: approximately double the weight loss with semaglutide at both dose levels Blood sugar control was also superior with semaglutide at all dose comparisons: Cardiovascular outcomes Both medications have demonstrated cardiovascular benefits, though in different trials

GLP-1 and GIP/GLP-1 medications have boxed warnings regarding thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and carry risks of pancreatitis, gallbladder disease, and diabetic retinopathy progression

Dietary Considerations : A balanced diet that supports immune function and overall health can play a role in preventing UTIs